Apollo Hospitals Enterprise moves up on getting nod to raise Rs 105 crore through NCDs
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Apollo Hospitals Enterprise is currently trading at Rs. 4759.00, up by 25.75 points or 0.54% from its previous closing of Rs. 4733.25 on the BSE.
The scrip opened at Rs. 4750.00 and has touched a high and low of Rs. 4783.20 and Rs. 4703.80 respectively. So far 10853 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5805.00 on 02-Dec-2021 and a 52 week low of Rs. 3365.90 on 26-May-2022.
Last one week high and low of the scrip stood at Rs. 4884.90 and Rs. 4642.00 respectively. The current market cap of the company is Rs. 68369.60 crore.
The promoters holding in the company stood at 29.33%, while Institutions and Non-Institutions held 64.60% and 6.07% respectively.
Apollo Hospitals Enterprise has received approval to raise Rs 105 crore through issue of 7.70% - 1050 Unsecured, Redeemable, Listed, Rated Non-Convertible Debentures (NCDs) face value of Rs 10 lakh each. Date of allotment of said NCDs will be on December 09, 2022 and date of maturity will be on January 09, 2024. The Committee of Directors (constituted by the Board of Directors of Apollo Hospitals Enterprise), at its meeting held on November 30, 2022, has approved the same.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.
